Invention Grant
- Patent Title: Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
-
Application No.: US16270302Application Date: 2019-02-07
-
Publication No.: US11266720B2Publication Date: 2022-03-08
- Inventor: Jennifer A. Dumont , Susan Low , Alan J. Bitonti , Glenn Pierce , Alvin Luk , Haiyan Jiang , Byron McKinney , Matt Ottmer , Jurg Sommer , Karen Nugent , Lian Li , Robert Peters
- Applicant: BIOVERATIV THERAPEUTICS INC.
- Applicant Address: US MA Waltham
- Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee Address: US MA Waltham
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.; James V. DeGiulio
- Main IPC: C07K14/755
- IPC: C07K14/755 ; A61K38/37 ; A61K47/64 ; A61K47/68 ; C07K16/46
Abstract:
The present invention provides methods of administering Factor VIII; methods of administering chimeric and hybrid polypeptides comprising Factor VIII; chimeric and hybrid polypeptides comprising Factor VIII; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Public/Granted literature
- US20190262429A1 FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF Public/Granted day:2019-08-29
Information query
